Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470710) titled 'Study on the Application of ¹8F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases' on March 3.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Neurodegenerative Diseases
Intervention:
Drug: 18F-FCOB04
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: March 9, 2026
Target Sample Size: 40
To know more, visit https://clinicaltrials.gov/study/NCT07470710
Disclaim...